Noked Israel Ltd Sells 18,550 Shares of Nova Ltd. $NVMI

Noked Israel Ltd lessened its holdings in shares of Nova Ltd. (NASDAQ:NVMI) by 13.6% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 117,987 shares of the semiconductor company’s stock after selling 18,550 shares during the period. Nova accounts for about 7.6% of Noked Israel Ltd’s portfolio, making the stock its 4th largest position. Noked Israel Ltd’s holdings in Nova were worth $51,239,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in NVMI. SG Americas Securities LLC lifted its position in Nova by 119.8% in the fourth quarter. SG Americas Securities LLC now owns 4,360 shares of the semiconductor company’s stock worth $1,432,000 after buying an additional 2,376 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in Nova by 21.4% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 38,565 shares of the semiconductor company’s stock valued at $12,664,000 after acquiring an additional 6,804 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. increased its position in Nova by 7.0% during the fourth quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,493,657 shares of the semiconductor company’s stock valued at $490,502,000 after acquiring an additional 98,000 shares during the last quarter. Mizuho Markets Americas LLC purchased a new stake in shares of Nova in the fourth quarter valued at $14,056,000. Finally, Legal & General Group Plc raised its stake in shares of Nova by 19.1% in the fourth quarter. Legal & General Group Plc now owns 145,427 shares of the semiconductor company’s stock valued at $48,642,000 after acquiring an additional 23,280 shares during the period. 82.99% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Needham & Company LLC raised their target price on shares of Nova from $500.00 to $640.00 and gave the stock a “buy” rating in a report on Thursday, May 14th. Barclays upped their price target on shares of Nova from $465.00 to $600.00 and gave the company an “overweight” rating in a report on Friday, May 15th. Weiss Ratings downgraded shares of Nova from a “hold (c+)” rating to a “hold (c)” rating in a research note on Tuesday, July 7th. Evercore restated an “outperform” rating and set a $600.00 target price on shares of Nova in a research report on Friday, May 15th. Finally, Jefferies Financial Group upped their target price on Nova from $520.00 to $640.00 and gave the company a “buy” rating in a research note on Thursday, May 14th. Eight investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Nova currently has a consensus rating of “Moderate Buy” and a consensus target price of $556.67.

Insider Activity at Nova

In other Nova news, Director Eitan Oppenhaim sold 1,290 shares of the company’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $581.20, for a total value of $749,748.00. Following the transaction, the director directly owned 6,421 shares in the company, valued at $3,731,885.20. This represents a 16.73% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Sarit Sagiv sold 454 shares of the firm’s stock in a transaction that occurred on Tuesday, June 23rd. The stock was sold at an average price of $536.52, for a total transaction of $243,580.08. Following the transaction, the director directly owned 1,951 shares in the company, valued at approximately $1,046,750.52. This trade represents a 18.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,798 shares of company stock valued at $4,125,266 in the last quarter. Corporate insiders own 1.00% of the company’s stock.

Nova Trading Up 0.2%

NASDAQ:NVMI opened at $455.37 on Friday. The company has a market cap of $14.47 billion, a price-to-earnings ratio of 56.78, a price-to-earnings-growth ratio of 3.29 and a beta of 1.74. Nova Ltd. has a twelve month low of $232.73 and a twelve month high of $615.99. The stock has a fifty day simple moving average of $502.74 and a 200-day simple moving average of $476.37.

Nova (NASDAQ:NVMI) last posted its quarterly earnings results on Thursday, May 14th. The semiconductor company reported $2.33 EPS for the quarter, topping analysts’ consensus estimates of $2.20 by $0.13. The firm had revenue of $235.31 million for the quarter, compared to analysts’ expectations of $227.02 million. Nova had a net margin of 29.21% and a return on equity of 21.77%. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same period in the prior year, the business posted $2.18 earnings per share. Nova has set its Q2 2026 guidance at 2.340-2.480 EPS. As a group, equities research analysts predict that Nova Ltd. will post 9.46 EPS for the current fiscal year.

Nova Company Profile

Nova Measuring Instruments Ltd (NASDAQ: NVMI) develops and supplies advanced metrology and process control systems for the semiconductor manufacturing industry. The company’s core product line includes spectroscopic ellipsometry and scatterometry tools designed to measure film thickness, critical dimensions, overlay alignment and other key parameters that drive yield and performance in integrated circuit fabrication.

Founded in 1993 and headquartered in Rehovot, Israel, Nova Measuring Instruments has established itself as a critical partner to leading semiconductor foundries and device manufacturers.